Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
RNA
Biotech
Merck KGaA swoops to $2B neurological disease pact with Skyhawk
Merck KGaA has swooped into a neurological-focused pact with RNA biotech Skyhawk Therapeutics that could top out at $2 billion.
James Waldron
Aug 18, 2025 9:49am
Bayer-allied NextRNA Therapeutics winds down operations
Aug 11, 2025 2:30pm
Flagship's Sail sends staff packing for 2nd time this year
Jul 18, 2025 12:55pm
AIRNA preps for clinical test with $155M series B
Apr 1, 2025 7:00am
Eli Lilly jumps deeper into AI with $409M Genetic Leap deal
Sep 5, 2024 9:16am
Pfizer signs $331M deal with Ginkgo for unspecified targets
Sep 27, 2023 9:50am
